(Q43270061)

English

Effect of Warm-Supplementing Kidney Yang (WSKY) added to risperidone on quality of life in patients with schizophrenia: a randomized controlled trial

scientific article published on 28 September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Effect of Warm-Supplementing Kidney Yang (WSKY) added to risperidone on quality of life in patients with schizophrenia: a randomized controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Zhen-hua Chen

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Gao-hua Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Xiao-ping Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Yun-xiang Huo

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Ming-hua Yang

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Li Li

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Hong-bing Mei

7

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

28 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Clinical Rehabilitation

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

963-972

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Pharmacologic treatment of schizophrenia.

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Drug treatment of the negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Training patients with schizophrenia with the community re-entry module: a controlled study

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Validation of the United States' version of the World Health Organization Quality of Life (WHOQOL) instrument.

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Help-seeking behaviors of Chinese patients with schizophrenia admitted to a psychiatric hospital.

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice: a naturalistic comparative study

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Schizophrenia and employment - a review

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Occupation, social support and quality of life in persons with schizophrenic or affective disorders.

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Association between demographic and diagnostic factors and employment outcomes for people with psychiatric disabilities: a synthesis of recent research

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Impact of atypical antipsychotics on quality of life, self-report of symptom severity, and demand of services in chronically psychotic patients.

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Selective Serotonin Reuptake Inhibitor (SSRI) Add-On Therapy for the Negative Symptoms of Schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Quality of life in patients with schizophrenia—comparison of self-report and proxy assessments

1 reference

https://api.crossref.org/works/10.1177%2F0269215508101743

21 January 2018

Identifiers

10.1177/0269215508101743

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43270061&oldid=1985248054"